Featured
Last news
The Naderi Center for Plastic Surgery Weighs In on What the Public Gets Wrong About Deep Plane Facelift Techniques and Longevity
Facial plastic surgeon explains how technique, tissue quality, and healing timelines influence facelift outcomes beyond social media speculation.
Hoover Presidential Foundation Unveils New Logo, Marking a Defining Moment Ahead of August Grand Reopening
WEST BRANCH, IA / ACCESS Newswire / May 28, 2026 / The Hoover Presidential Foundation today announced the introduction of its new logo, a modern identity that reflects a broader, more complete telling of Herbert Hoover's life and legacy. The unveiling comes as the Foundation prepares for the highly anticipated grand reopening of the Herbert Hoover Presidential Library and Museum on August 6, 2026.
SoCal Aesthetic Surgery Named "Best of 2026" by BusinessRate for Excellence in Plastic Surgery
BusinessRate recognition reflects consistently positive patient feedback and trusted facial plastic surgery care in Irvine and throughout Orange County.
Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders
Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation, is being developed as the potential first oral adjunctive therapy for Intestinal Failure (IF) from microvillus inclusion disease (MVID) and short bowel syndrome (SBS)Crofelemer development with novel formulations for different gastrointestinal disorders reflects a differentiated botanical drug platform integrating ethnobotanical medicine, sustainable harvesting, complex CMC, and novel bioassays to support approval under FDA botanical guidanceTraditional knowledge of Croton lechleri use supported ethnobotanical research that led to development and approval of crofelemer, whose first in class anti-secretory mechanism was characterized through modern pharmacology and mechanism-based bioassays. Recent milestones include continued evaluation in an extension phase for Jaguar family company Napo's pivotal clinical trial of crofelemer as adjunctive therapy to Parenteral Support (PS) for MVID and upcoming ESPGHAN presentations in pediatric MVID and SBS-IF patientsFDA approval of crofelemer as an oral botanical drug highlights the totality-of-evidence and creates a significant practical barrier to generic replication
Will Physicians Risk Their Licenses For CMS Hemp Products The FDA Never Approved?
"As SAM (Smart Approaches To Marijuana) and MMJ International Holdings Prepare an Appeal, Medicare Doctors Now Stand Between Seniors and Uncharacterized, Unsafe Hemp Products," stated Duane Boise, CEO MMJ International Holdings.
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing
FORT LAUDERDALE, FL / ACCESS Newswire / May 28, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a leading pharmaceutical company specializing in generic and specialty prescription medications, today announced a one for ten reverse split of its common stock, effective at market open on June 1, 2026. The reverse stock split was undertaken to regain compliance with Nasdaq's minimum bid price requirement for continued listing. The reverse stock split will reduce the Company's issued and outstanding shares of common stock from 21,236,346 to approximately 2,123,635.
Medical Care Technologies (OTC PINK:MDCE) Provides Additional Details Regarding MDCE Melanoma Scan Beta Imaging Platform
Company discusses AI-assisted body-map monitoring architecture and long-term imaging technology development initiatives
Patient Safety Movement Foundation Appoints Three Distinguished Leaders to Governance Board
Global nonprofit strengthens leadership with expertise spanning government, medicine, and international healthcare systems in pursuit of zero preventable patient harm
TRNR Updates Investor Presentation Detailing Acquisition Strategy and Increased M&A Pipeline
AUSTIN, TX / ACCESS Newswire / May 28, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today published an updated investor presentation detailing its acquisition-driven operating strategy, the contribution of recently completed acquisitions, and an increased M&A pipeline.
Aspire Biopharma Issues Shareholder Letter
ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson.
Phase 1 Equity Announces Its Third Practice Addition of the Year, Bringing on a Multi-Site Orthodontic Practice Located in Texas
CHICAGO, IL / ACCESS Newswire / May 28, 2026 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in Texas to its growing network.
Black Book to Release 2026 Top Vendor Client Satisfaction Results Ahead of AHIP26 and HFMA Annual Conferences
Thousands of validated payer IT users and provider finance, business office, RCM and reimbursement professionals contribute category-specific evaluations across 90 healthcare technology and managed services functions
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
Experienced oncology R&D leader appointed to support Aptevo's expanding oncology pipeline and new radiopharmaceutical development strategy
Harrier Sundown Celebration Honors 40+ Years of Squadron History and AV-8B Retirement
June 2026 event welcomes squadron veterans and families back to Marine Corps Air Station Cherry Point for a once-in-a-generation farewell.
Wellgistics Health Announces Lock-Up Agreement with Holders of a Majority of its Common Stock
Holders of 1,333,930 common shares agree to minimum 90-day lock-up agreement
Reservoir Media Announces Fourth Quarter and Fiscal Year 2026 Results
Strong Execution and Substantial Capital Deployment Drove Record Financial Performance and High-Quality Portfolio ExpansionFiscal 2027 Financial Outlook of Mid-Single-Digit Top- and Bottom-Line Growth
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026
NEWARK, CA / ACCESS Newswire / May 28, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in two investment bank conferences taking place in June 2026.
INEO Tech Corp. Reports Record Quarterly Revenue For Fiscal Q3 FY2026
SURREY, BC / ACCESS Newswire / May 28, 2026 / INEO Tech Corp. (TSX-V:INEO)(OTCQB:INEOF) (the "Company" or "INEO"), a retail technology company modernizing store entrance infrastructure through connected loss prevention, digital media and operational intelligence solutions, today announced its financial results for the three months ended March 31, 2026 (the "Quarter"). The Company's unaudited interim condensed consolidated financial statements and management's discussion and analysis have been filed and are available under the Company's profile on SEDAR+.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 28
LONDON, UK / ACCESS Newswire / May 28, 2026 / The Company announces that on 27 May 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Assistant who injected Matthew Perry with drugs sentenced to 41 months
The personal assistant who repeatedly injected Matthew Perry with ketamine was sentenced to prison on Wednesday, becoming the fifth person to face justice over the "Friends" star's fatal overdose.
'Trump' buffalo spared sacrifice, sent to Bangladesh zoo
A buffalo in Bangladesh nicknamed "Donald Trump" for its flowing blond hair has been spared from sacrifice after shooting to fame, and will instead be cared for at the national zoo.
Duterte's ICC trial to start November 30: judge
Former Philippines president Rodrigo Duterte will face a crimes against humanity trial at the International Criminal Court from November 30, the presiding judge said on Wednesday.
Pilgrims 'stone the devil' at hajj gripped by intense heat
Muslim faithful ritually stoned the devil on Wednesday in the climactic ceremony of a hajj pilgrimage held in intense heat and against the backdrop of a war that has plunged the wealthy Gulf into crisis.
Hajj pilgrims stone the devil in final ritual
Muslim faithful took part in the climactic ritual of the annual hajj pilgrimage on Wednesday, symbolically stoning the devil near Mecca.
Patriotic Country Rocker and American Rebel Holdings, Inc. (OTC:AREB) CEO Andy Ross to Appear Live on Dr. Drew Tonight to Discuss 2nd Amendment and Company's Patriotic Values
American Rebel Holdings (OTC:AREB) CEO Andy Ross brings America's Patriotic Brand(TM), American Rebel Light Beer, "Hold My Beer," and a bullish faith-family-freedom message to Dr. Drew's national audience as America approaches its 250th birthday
Wellgistics Health Refinances Outstanding Convertible Debt and Raises $6.5M
New oversubscribed $21 million convertible debt instrument ("New Debt") refinances all outstanding convertible debt, provides $6.5 million in new capital for working capital and general corporate purposes does not accrue interest and converts into common shares at $6.00 per shareAutomatic Exchange provision automatically converts the New Debt into Preferred Stock upon the effectiveness of a registration statement and attainment of shareholder approval for the creation of Preferred StockThe class of Preferred Stock that the New Convertible Debt exchanges into (the "Funding Preferred") converts into common shares at $50.00 per shareNew funds raised satisfy capital raising closing condition from Fully Binding Term Sheet with Datavault AI, EOS Technology Holdings, Scilex Pharma and HealthBridge Advisors
Organto Foods Announces Appointment of Darryl Bergman as President
Brings Extensive Operating, Financial, Strategic Growth and Public Company Experience to Organto
Ontario Airport Hotel & Conference Center to Debut as Hyatt Regency Ontario Following Property-Wide Transformation
Reimagined Property Set to Introduce a New Era of Elevated Design, Service and Culinary Excellence in the Inland Empire
NordicNeuroLab and GE HealthCare Enter Strategic Software License and Distribution Agreement to Advance Neuroimaging Worldwide
A collaboration for advancing neuroimaging
2026 Membrane Technology Forum Expands Focus on Beverage Innovation and Wastewater Treatment
Annual forum will highlight new technologies, market opportunities for food and beverage development, and processing wastewater treatment.
Dolphin Celebrates The 2026 Cannes Film Festival with Legacy Talent, High-Profile Premieres, Emerging Filmmakers, And Prestigious Brands
Subsidiary 42West Spearheads Major Activations on the Croisette with Guillermo del Toro, Bruce Dern, Clarissa directors Arie and Chuko Esiri and producer Theresa Park, and The American Pavilion Presented by IndieWire
Jaguar Health Compliant with Nasdaq Bid Price Rule
JAGX's securities continue to be listed and traded on Nasdaq